Fertility Preservation and Reproduction in Patients Facing Gonadotoxic Therapies: A Committee Opinion

Fertil Steril. 2013 Nov;100(5):1224-31. doi: 10.1016/j.fertnstert.2013.08.041. Epub 2013 Oct 2.

Abstract

Chemotherapy and radiation therapy often result in reduced fertility, and patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. Reproduction in the context of cancer also raises a number of ethical issues related to the welfare of both patients and offspring. This document replaces the document titled, "Fertility preservation and reproduction in cancer patients," last published in 2005 (Fertil Steril 2005;83:1622-8).

Publication types

  • Practice Guideline

MeSH terms

  • Age Factors
  • Antineoplastic Agents / adverse effects*
  • Castration / adverse effects*
  • Female
  • Fertility Preservation / adverse effects
  • Fertility Preservation / methods
  • Fertility Preservation / standards*
  • Fertility* / drug effects
  • Fertility* / radiation effects
  • Gonads* / drug effects
  • Gonads* / pathology
  • Gonads* / physiopathology
  • Gonads* / radiation effects
  • Gonads* / surgery
  • Humans
  • Infertility / etiology
  • Infertility / pathology
  • Infertility / physiopathology
  • Infertility / therapy*
  • Male
  • Neoplasms / therapy*
  • Patient Care Team / standards
  • Patient Selection
  • Radiation Injuries / etiology
  • Radiation Injuries / pathology
  • Radiation Injuries / physiopathology
  • Radiation Injuries / therapy*
  • Radiotherapy / adverse effects
  • Risk Assessment
  • Risk Factors
  • Sex Factors

Substances

  • Antineoplastic Agents